Longevity Health Holdings, Inc. Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest
Longevity Health Holdings, Inc. (XAGE) reported Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest of -$6.91 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest · last filed 2026-03-31
- Longevity Health Holdings, Inc. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2025-12-31 was -$2.08M.
- Longevity Health Holdings, Inc. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2025-09-30 was -$1.43M.
- Longevity Health Holdings, Inc. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2025-06-30 was -$1.89M.
- Longevity Health Holdings, Inc. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2025-03-31 was -$1.51M.
- Longevity Health Holdings, Inc. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for fiscal 2025 was -$6.91M.
- Longevity Health Holdings, Inc. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for fiscal 2024 was -$10.65M.
- Longevity Health Holdings, Inc. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for fiscal 2023 was -$16.21M.
- Longevity Health Holdings, Inc. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for fiscal 2022 was -$9.05M.
| Period end | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 3 month | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 6 month | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 9 month | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 12 month |
|---|---|---|---|---|
| 2025-12-31 | -$2.08M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$3.51M derived: sum of 2 quarters · filed 2026-03-31 | -$5.40M derived: sum of 3 quarters · filed 2026-03-31 | -$6.91M 10-K · filed 2026-03-31 |
| 2025-09-30 | -$1.43M 10-Q · filed 2025-11-14 | -$3.32M derived: sum of 2 quarters · filed 2025-11-14 | -$4.82M 10-Q · filed 2025-11-14 | -$5.74M derived: sum of 4 quarters · filed 2026-03-31 |
| 2025-06-30 | -$1.89M 10-Q · filed 2025-08-14 | -$3.39M 10-Q · filed 2025-08-14 | -$4.31M derived: sum of 3 quarters · filed 2026-03-31 | -$7.19M derived: sum of 4 quarters · filed 2026-03-31 |
| 2025-03-31 | -$1.51M 10-Q · filed 2025-05-15 | -$2.42M derived: sum of 2 quarters · filed 2026-03-31 | -$5.30M derived: sum of 3 quarters · filed 2026-03-31 | -$8.60M derived: sum of 4 quarters · filed 2026-03-31 |
| 2024-12-31 | -$914.28K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$3.79M derived: sum of 2 quarters · filed 2026-03-31 | -$7.10M derived: sum of 3 quarters · filed 2026-03-31 | -$10.65M 10-K · filed 2026-03-31 |
| 2024-09-30 | -$2.88M 10-Q · filed 2025-11-14 | -$6.18M derived: sum of 2 quarters · filed 2025-11-14 | -$9.74M 10-Q · filed 2025-11-14 | -$9.75M derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-06-30 | -$3.30M 10-Q · filed 2025-08-14 | -$6.86M 10-Q · filed 2025-08-14 | -$6.87M derived: sum of 3 quarters · filed 2025-08-14 | -$15.93M derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | -$3.55M 10-Q · filed 2025-05-15 | -$3.56M derived: sum of 2 quarters · filed 2025-06-17 | -$12.62M derived: sum of 3 quarters · filed 2025-06-17 | -$17.93M derived: sum of 4 quarters · filed 2025-06-17 |
| 2023-12-31 | -$8.94K derived: 10-K/A 12 month − 10-Q 9 month · filed 2025-06-17 | -$9.07M derived: sum of 2 quarters · filed 2025-06-17 | -$14.38M derived: sum of 3 quarters · filed 2025-06-17 | -$16.21M 10-K/A · filed 2025-06-17 |
| 2023-09-30 | -$9.06M 10-Q · filed 2024-11-14 | -$14.37M derived: sum of 2 quarters · filed 2024-11-14 | -$16.20M 10-Q · filed 2024-11-14 | |
| 2023-06-30 | -$5.31M 10-Q · filed 2024-08-14 | -$7.14M 10-Q · filed 2024-08-14 | ||
| 2023-03-31 | -$1.83M 10-Q · filed 2024-05-15 | |||
| 2022-12-31 | -$9.05M 10-K · filed 2024-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STEPAN CO (SCL) | United States | $1.451B | -477.05 |
| CHURCH & DWIGHT CO INC /DE/ (CHD) | United States | $22.622B | 30.81 |
| ECOLAB INC. (ECL) | United States | $77.183B | 36.58 |
| PROCTER & GAMBLE Co (PG) | United States | $338.763B | 21.26 |